Development, validation and utilization of a highly sensitive LC-MS/MS method for quantification of levonorgestrel released from a subdermal implant in human plasma

類似資料

• The development and validation of a novel LC-MS/MS method for the simultaneous quantification of Molnupiravir and its metabolite ß-d-N4-hydroxycytidine in human plasma and saliva
  著者:: Amara, Alieu, 等
  出版事項: (2021)
• Development, validation and clinical application of a method for the simultaneous quantification of lamivudine, emtricitabine and tenofovir in dried blood and dried breast milk spots using LC–MS/MS
  著者:: Waitt, Catriona, 等
  出版事項: (2017)
• Efavirenz- but not nevirapine-based antiretroviral therapy decreases exposure to the levonorgestrel released from a sub-dermal contraceptive implant
  著者:: Scarsi, Kimberly, 等
  出版事項: (2014)
• Development, validation and clinical application of a novel method for the quantification of efavirenz in dried breast milk spots using LC-MS/MS
  著者:: Olagunju, Adeniyi, 等
  出版事項: (2015)
• Determination of the Rifamycin Antibiotics Rifabutin, Rifampin, Rifapentine and their Major Metabolites in Human Plasma via Simultaneous Extraction Coupled with LC/MS/MS
  著者:: Winchester, Lee C., 等
  出版事項: (2014)